Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.28697
Abstract: Although nonalcoholic fatty liver disease (NAFLD) is closely linked to obesity, around 10%‐20% of nonobese Americans and Asians still develop NAFLD. Data on this special group are limited. We therefore studied the severity and clinical… read more here.
Keywords: nonobese patients; fatty liver; disease; nonalcoholic fatty ... See more keywords
Dofetilide Dose Reductions and Discontinuation in Obese Compared with Nonobese Patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000001353
Abstract: Abstract: Dofetilide is an antiarrhythmic agent and primarily eliminated renally. Initial dosing is determined by creatinine clearance, calculated by total body weight in the Cockcroft–Gault equation. To date, there is no evidence comparing the dosing… read more here.
Keywords: adjustments compared; body weight; nonobese patients; dose reductions ... See more keywords
Comparable efficacy and safety of brodalumab in obese and nonobese patients with psoriasis: analysis of two randomized controlled trials
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.18327
Abstract: Obesity is associated with psoriasis and negatively affects response to therapy. read more here.
Keywords: brodalumab obese; safety brodalumab; nonobese patients; efficacy safety ... See more keywords
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION
Sign Up to like & getrecommendations! Published in 2022 at "Circulation: Cardiovascular Interventions"
DOI: 10.1161/circinterventions.121.011069
Abstract: Background: In randomized trials, cangrelor reduced periprocedural ischemic events related to percutaneous coronary intervention without increasing GUSTO severe bleeding. However, some antiplatelet agents have shown a differential treatment effect by body mass index (BMI). Methods:… read more here.
Keywords: cangrelor; platelet inhibition; cangrelor versus; obese patients ... See more keywords
Time to Target Anti-Xa Level in Obese Vs Nonobese Patients Using an Adjusted Body Weight Heparin Infusion Protocol for the Treatment of Venous Thromboembolism
Sign Up to like & getrecommendations! Published in 2025 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280251321478
Abstract: Background: Unfractionated heparin (UFH) is a first-line option for the acute treatment of venous thromboembolism (VTE). Weight-based dosing protocols have demonstrated a decreased time to therapeutic anticoagulation, however, there are limited data on their utilization… read more here.
Keywords: time; obese nonobese; nonobese patients; target ... See more keywords
The median effective dose of ciprofol combined with a low-dose sufentanil for gastroscopy in obese or nonobese patients: a dose-finding study using Dixon’s up-and-down method
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2025.1521715
Abstract: Objectives Understanding the different pharmacodynamic responses to narcotics in patients with or without obesity is particularly important for the safety of gastroscopy sedation. This study aimed to determine the median effective dose (ED50) of ciprofol… read more here.
Keywords: median effective; dose; obese nonobese; nonobese patients ... See more keywords
Comparison of I-gel for general anesthesia in obese and nonobese patients
Sign Up to like & getrecommendations! Published in 2018 at "Saudi Journal of Anaesthesia"
DOI: 10.4103/sja.sja_79_18
Abstract: Context: I-gel is a second-generation supraglottic airway device. Despite several studies on i-gel, there are very few studies on the use of i-gel in obese patients. Aims: The aim of the study was to compare… read more here.
Keywords: nonobese patients; obese nonobese; group; gel general ... See more keywords